Breda, Netherlands

Peter Jacobus Johannes Buijnsters


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • JX Breda, NL (2007)
  • Etten-Leur, NL (2013)
  • Beerse, BE (2015)
  • Breda, NL (2010 - 2016)

Company Filing History:


Years Active: 2007-2016

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Peter Jacobus Johannes Buijnsters: Innovator in Antiproliferative Compounds

Introduction

Peter Jacobus Johannes Buijnsters is a notable inventor based in Breda, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antiproliferative activity. With a total of 5 patents to his name, Buijnsters has established himself as a key figure in his area of expertise.

Latest Patents

One of his latest patents involves the creation of 3-cyano-quinoline derivatives with antiproliferative activity. This invention concerns the compounds of formula, including the N-oxide forms, the pharmaceutically acceptable addition salts, and the stereochemically isomeric forms thereof. These compounds hold promise for therapeutic applications in combating various diseases.

Career Highlights

Buijnsters is currently associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work at Janssen has allowed him to focus on innovative research and development, contributing to advancements in medical science.

Collaborations

Throughout his career, Buijnsters has collaborated with esteemed colleagues, including Eddy Jean Edgard Freyne and Kristof Van Emelen. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Peter Jacobus Johannes Buijnsters is a distinguished inventor whose work in antiproliferative compounds has made a significant impact in the pharmaceutical field. His innovative contributions continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…